Clinical Trial Update: Anti-Hep B Antibodies at Age 12 to 18 Months After Hep B Vaccine at Birth and DTaP-IPV-Hep B-PRP-T Hexavalent Vaccine Concomitantly With Prevnar® at 2, 4 and 6 Months of Age [NA]

View source ↗

Summary

Clinical trial update examining anti-Hepatitis B antibodies at 12-18 months after birth Hepatitis B vaccination and coadministration of a DTaP-IPV-HepB-PRP-T he…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• DTaP-IPV-HepB-PRP-T hexavalent vaccine (DTaP-IPV-HepB-PRP-T hexavalent vaccine)
• Hepatitis B vaccine (Hepatitis B vaccine)
• Prevnar (pneumococcal conjugate vaccine)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Hepatitis B | NA | Status: COMPLETED